HealthSplash Owner Gets 19 Years in Massive Medicare Fraud Case
A federal judge sentenced Brett Blackman, the owner and CEO of healthcare software company HealthSplash, to 19 years in prison for his role in a sprawling Medicare fraud scheme that prosecutors said pushed more than $1 billion in false claims through federal healthcare programs. The case centered on durable medical equipment, kickbacks, and telemedicine orders issued without meaningful patient contact.
The sentence lands squarely in the center of a fraud model that exploited ordinary clinical pathways for profit. Orthotic braces, prescriptions, and related equipment were not being routed through legitimate bedside assessment or a credible telehealth encounter. Instead, prosecutors said the operation turned medical necessity into a billing exercise.
How the Billing Scheme Operated
Blackman, 43, of Johnson County, Kansas, was sentenced Oct. 14 after a April conviction on multiple charges: conspiracy to commit healthcare fraud and wire fraud, conspiracy to pay and receive kickbacks, and conspiracy to defraud the United States and make false statements in connection with healthcare matters. A Justice Department release dated Oct. 15 laid out the conduct behind the verdict.
HealthSplash acquired Power Mobility Doctor Rx, also known as DMERx, in 2017. Prosecutors said the web-based platform generated fraudulent physicians’ orders for durable medical equipment and prescriptions. Rather than serving as a neutral administrative tool, the platform connected pharmacies, equipment suppliers, and marketers with telemedicine companies that accepted illegal kickbacks and bribes.
The structure mattered because it bypassed the core clinical safeguard in medical ordering: a real evaluation of symptoms, function, and indication. Telemedicine physicians were paid to sign orders without meaningful interaction with patients, and in some cases without any interaction at all. In practical terms, the system converted physician signatures into a commodity and detached orders from patient need.
Patients Became the Sales Target
Prosecutors said the conspiracy targeted hundreds of thousands of Medicare beneficiaries and pressured them to accept orthotic braces and other items that were not medically necessary. Medicare was billed for braces for more than 346,000 beneficiaries, with an average of four braces per person. That volume is hard to reconcile with routine musculoskeletal care; it points instead to a mass-marketing pipeline designed to maximize reimbursement rather than treat disease.
The claims were not small or isolated. Suppliers and pharmacies involved in the operation billed Medicare and other insurers more than $1 billion and received more than $450 million in payments, according to the release. Those figures frame the scale of the loss, but they also reveal the clinical harm baked into the model: patients were steered toward products they did not need, while the medical record was reduced to paperwork that supported payment.
A one-sentence truth defines the case: the medical order was treated as a billing tool, not a treatment decision.
Kickbacks, Bribes, and the Breakdown of Clinical Judgment
Kickbacks alter care before the first claim is ever submitted. Once money is attached to the referral path, the system stops selecting services by necessity and starts selecting them by profitability. In this case, prosecutors said the telemedicine companies accepted illegal payments, and physicians were induced to approve orders with little or no patient contact. That combination strips away the usual clinical checks that protect Medicare beneficiaries from unnecessary devices and prescriptions.
Orthotic braces may have a legitimate role in selected conditions, but only when there is a documented indication, a proper assessment, and a reasonable expectation of benefit. When the ordering process is corrupted, the device itself becomes secondary to the fraudulent pathway used to justify reimbursement. The result is not merely improper billing; it is the erosion of trust in telemedicine, durable medical equipment prescribing, and the clinicians whose names appear on the orders.
Sentencing Reflects the Scale of the Fraud
Blackman’s sentence of 19 years places him among the central figures in one of the larger federal healthcare fraud cases tied to durable medical equipment and telemedicine ordering. The court will determine restitution and forfeiture at a later date.
His co-defendant, Gary Cox, was sentenced in December 2025 to 15 years in prison and ordered to pay more than $452 million in restitution. Cox, 79, was CEO of DMERx. The separate sentence indicates how much of the scheme appears to have relied on platform-level coordination rather than a single rogue actor. In fraud cases built around healthcare software and remote prescribing, the software itself can become the engine of abuse when controls fail or are deliberately bypassed.
The case also shows why enforcement agencies have increasingly focused on the junction between telehealth, pharmacies, suppliers, and marketers. Each link in that chain can be legitimate on its own, yet the entire structure collapses when patient interaction becomes optional and claims generation becomes the real product.
What the Case Means for Medicare Oversight
For Medicare, the immediate concern is not just repayment. It is the vulnerability of benefit structures that depend on a valid physician order. Durable medical equipment claims can move quickly, especially when telemedicine and remote documentation are used to scale volume. Once illegitimate orders are paired with compliant billing infrastructure, detection becomes harder and losses accumulate fast.
The scale here is striking: hundreds of thousands of beneficiaries, more than 346,000 billed for braces, more than $1 billion submitted to insurers, and more than $450 million paid out. Those figures suggest an operation built for throughput, not care delivery. The clinical consequence is subtler but real: beneficiaries may receive products they do not need, while legitimate patients face greater scrutiny, slower approvals, and more suspicion around telemedicine-based ordering.
Restitution and forfeiture will follow, but the larger issue is the integrity of medical decision-making itself. When ordering platforms are designed around compensation rather than consultation, the line between healthcare and fraud disappears quickly. In this case, federal prosecutors said that line was crossed at scale, and the sentence reflects how seriously the justice system viewed the damage.